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Maternal thyroid disorder in pregnancy and
risk of cerebral palsy in the child: a
population-based cohort study
Tanja Gram Petersen1* , Anne-Marie Nybo Andersen1, Peter Uldall2, Nigel Paneth3, Ulla Feldt-Rasmussen4,
Mette Christophersen Tollånes5 and Katrine Strandberg-Larsen1
Abstract
Background: Cerebral palsy is the most frequent motor disability in childhood, but little is known about its etiology. It
has been suggested that cerebral palsy risk may be increased by prenatal thyroid hormone disturbances. The objective
of this study was to investigate whether maternal thyroid disorder is associated with increased risk of cerebral palsy.
Methods: A population-based cohort study using two study populations. 1) 1,270,079 children born in Denmark 1979–2007
identified in nationwide registers, and 2) 192,918 children born 1996–2009 recruited into the Danish National Birth Cohort
and The Norwegian Mother and Child Cohort study, combined in the MOthers and BAbies in Norway and Denmark
(MOBAND) collaboration cohort. Register-based and self-reported information on maternal thyroid disorder was studied in
relation to risk of cerebral palsy and its unilateral and bilateral spastic subtypes using multiple logistic regression. Children
were followed from the age of 1 year to the age of 6 years, and cerebral palsy was identified in nationwide registers with
verified diagnoses.
Results: In register data, hypothyroidism was recognized in 12,929 (1.0%), hyperthyroidism in 9943 (0.8%),
and unclassifiable thyroid disorder in 753 (< 0.1%) of the mothers. The odds ratio for an association between
maternal thyroid disorder and bilateral spastic cerebral palsy was 1.0 (95% CI: 0.7–1.5). Maternal thyroid
disorder identified during pregnancy was associated with elevated risk of unilateral spastic cerebral palsy
(odds ratio 3.1 (95% CI: 1.2–8.4)). In MOBAND, 3042 (1.6%) of the mothers reported a thyroid disorder in
pregnancy, which was not associated with cerebral palsy overall (odds ratio 1.2 (95% CI: 0.6–2.4)).
Conclusions: Maternal thyroid disorder overall was not related to bilateral spastic cerebral palsy, but maternal
thyroid disorder identified in pregnancy was associated with increased risk of unilateral spastic cerebral palsy.
These findings should be replicated in studies making use of maternal blood samples.
Keywords: Maternal thyroid disorder, Pregnancy, Prenatal exposure, Cerebral palsy, The Danish National Birth
Cohort, The Norwegian mother and child cohort study, Register-based cohort
Background
Cerebral palsy (CP) is the most prevalent severe motor
disability in childhood affecting approximately 2 per
1000 live-born children [1]. Recent studies have sug-
gested that birth complications constitute only a small
part of the factors contributing to the multifactorial eti-
ology of CP, and that most CP risk factors probably
operate prenatally [2]. Several studies have demonstrated
that elevated maternal serum levels of thyrotropin and
low thyroid hormone in pregnancy may affect child neu-
rodevelopment, including motor function [3–6]. A num-
ber of studies have linked thyroid hormone disturbances
of mothers or newborns to CP [7–11], but not every
study finds the association [12].
Endogenous fetal thyroid hormone production begins
around 10-18th week of gestation. The fetus, therefore,
depends on maternal thyroid hormone entirely in early
pregnancy, and from mid-gestation fetal thyroid hormone
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production acts in concert with the maternal
hypothalamic-pituitary-thyroid axis [8, 13, 14]. Thyroid
hormone is required for many aspects of brain develop-
ment, including myelination of nerve cells, and insuffi-
cient myelination is often present in individuals with CP
[8, 15]. Moreover, hypo- and hyperthyroidism are corre-
lated with coagulation abnormalities that can lead to is-
chemia or bleeding, which may underlie unilateral spastic
CP [16, 17]. Thyroid diseases are difficult to stabilize with
treatment, especially in pregnancy [18], and it is not un-
usual for overtreatment to lead women diagnosed with
hypothyroidism to have elevated thyroid hormone levels
and women with hyperthyroidism to have reduced thyroid
hormone levels. Thus, we aimed to investigate the associ-
ation between maternal thyroid disorder in pregnancy and
risk of cerebral palsy in the child in two study populations
in Denmark and Norway, each one with a distinct re-
search advantage. One study population permitted exam-
ination of different thyroid disorder and CP subtypes in a
very large study sample, while the other provided oppor-
tunities for performing analyses that controlled for life-
style factors.
Methods
Study design and populations (Fig. 1)
One study population is register-based and comprises
children born in the eastern part of Denmark in 1979–
1996, and children born in all of Denmark in 1997–
2007. In total, 1,277,101 live births were identified
through the Danish Civil Registration System [19].
Individual-level data from nationwide registers on the
children and their mothers were linked by use of the
unique personal identifier to which all live-born children
in Denmark are assigned. We excluded infant deaths (n =
7022), leaving 1,270,079 children for the final analyses.
The other study population is derived from the
MOthers and BAbies in Norway and Denmark
(MOBAND) collaboration cohort [20], which consists of
pooled data from the Danish National Birth Cohort
(DNBC) and The Norwegian Mother and Child Cohort
study (MoBa) [21, 22]. MOBAND includes 210,400
live-born children born in 1996–2009 on whom detailed
information on prenatal exposures was obtained around
gestational week 16 and 31 by telephone interviews in
DNBC, and around gestational week 17 and 30 by
self-administered questionnaires in MoBa, as described
in more detail elsewhere [20]. We excluded children
without any prenatal information from the earliest data
collection (n = 16,691), infant deaths (n = 634), and chil-
dren with incomplete information on maternal thyroid
disorder (n = 157), leaving 192,918 children for the final
analyses.
Register-based data
Diagnoses of thyroid disorder in the Danish mothers
were derived from the Danish National Patient Register
[23], which keeps information on hospital admissions
since 1977 and outpatient visits since 1995. Until 1994,
all diagnoses were coded using the eighth version of the
Internal Classification of Diseases (ICD-8), and since
Fig. 1 Flowchart of the register-based study population and MOBAND study population. Abbreviations: MOBAND, MOthers and BAbies in Norway
and Denmark (MOBAND). DNBC, Danish National Birth Cohort. MoBa, Norwegian Mother and Child Cohort study
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1995, the tenth version (ICD-10). The Danish National
Prescription Registry [24], established in 1995, provided
the Anatomical Therapeutic Chemical (ATC) codes indi-
cating redeemed prescriptions dispensed from Danish
pharmacies. The Danish Medical Birth Registry [25] and
population registers in Statistics Denmark [26] provided
information on characteristics of the Danish partici-
pants, while the Medical Birth Registry of Norway [27]
provided information on the Norwegian participants.
Exposure to maternal thyroid disorder
Maternal hypothyroidism and hyperthyroidism in the
register-based study population were defined by a
hospital diagnosis and at least one redeemed prescrip-
tion of the appropriate medication, i.e. thyroid hor-
mone (ACT-code: H03A) for hypothyroidism and
anti-thyroid medication (ACT-code: H03B) for hyper-
thyroidism, to enhance the validity of the identified
disorders. Hypothyroidism was identified by ICD-8
codes 243.99 and 244.00–244.09, and by ICD-10
codes E00, E03.0-E03.9 and E89.0, excluding 244.02,
E03.0A, E03.1B, and E03.4. Hyperthyroidism was
identified by ICD-8 as 242.00–242.29 and by ICD-10
as E05.0-E05.9, excluding E05.4, E05.8A, and E05.9A.
There were some exceptions; when a first-time diag-
nosis was recorded before the establishment of the
Danish National Prescription Registry in 1995, the
diagnosis code exclusively determined exposure status.
Further, as the Danish National Patient Register does
not keep information on diagnoses made by general
practitioners, we also defined hypothyroidism by at
least two redemptions of thyroid hormone prescrip-
tions and no redemptions of anti-thyroid medication
prescription, and we defined hyperthyroidism by at
least two redemptions of anti-thyroid prescriptions;
regardless of thyroid hormone prescriptions, in case of no
record of thyroid diagnosis [28–30] (see Additional file 1:
eMethod 1 for information on additional coding). We in-
cluded all thyroid disorders recorded until 5 years subse-
quent to pregnancy until 2010 inclusive. Time of
identification of thyroid disorder was defined as the day of
the first diagnosis code or redeemed prescription, which-
ever was recorded first, and categorized into; ‘before preg-
nancy’, ‘during pregnancy’, and ‘within 5 years after
pregnancy’.
In MOBAND, information on maternal thyroid dis-
order in pregnancy was based on self-reports from the
earliest data collection in pregnancy, which was around
16–17 weeks of gestation. The data collected in MoBa
only distinguished thyroid disorder overall and could not
separate hypo- and hyperthyroidism. We used informa-
tion from the second pregnancy interview of DNBC and
the earliest questionnaire of MoBa to define the use of
thyroid medication in pregnancy.
Cases of cerebral palsy
Danish CP cases were identified through the Danish Na-
tional Cerebral Palsy Registry that includes all children
surviving the first year of life with a neuro-pediatrician
validated diagnosis of CP at age five-six years [31, 32]. In
1979–1996 the register covered the eastern part of
Denmark, and in 1997–2007 it was nationwide. Ap-
proximately 80% of the Norwegian cases were identified
though the Cerebral Palsy Registry of Norway [33]. The
remaining cases were identified in record linkage with
the Norwegian Patient Registry and verified by
neuro-pediatricians’ examinations of medical records
[34]. We assessed all CP subtypes combined and the two
major subtypes: unilateral and bilateral spastic CP.
Covariates
We used register-based data to form the variables: the
year of child’s birth, maternal age (< 25, 25–29, 30–34,
≥35 years), child’s sex (boy, girl), gestational age (≥37, <
37 weeks of gestation), and maternal diabetes (no, type
1, type 2) for both study populations. For the
register-based study population, we also obtained infor-
mation from administrative registers about maternal
educational level (basic, intermediate, higher). In
MOBAND, we used self-reported information on mater-
nal occupational status (employed, unemployed, student,
receiving benefits or pension), maternal alcohol con-
sumption per week (0, 0.5, 1–2.5, ≥3 units), and number
of cigarettes smoked per day (0, 1–9, ≥10); all reported
in the earliest data collection.
Statistical analyses
We used logistic regression to estimate odds ratios (OR)
with 95% confidence intervals (95% CIs) for the relation-
ship of CP with maternal thyroid disorder. Robust stand-
ard errors were used to take into account the potential
dependency between siblings. To guide our decision about
which potential confounders we should adjust for, we used
Directed Acyclic Graphs [35]. The adjusted models in-
cluded the child’s birth year, maternal diabetes, maternal
age, and maternal socioeconomic position (education/oc-
cupation), and in addition smoking and alcohol consump-
tion in pregnancy in the MOBAND study population. We
imputed missing values of covariates by use of multiple
imputations (see Additional file 1: eMethod 2).
In the register-based study population, we stratified by
child’s sex and gestational age, respectively, to explore
whether exposure to maternal thyroid disorder has a
greater impact on risk of CP in boys and children born
at term. Potential misclassification of exposure was
assessed by examining the agreement of self-reported
and register-based information on maternal thyroid dis-
order in the 90,088 Danish children included in both the
register-based and MOBAND study population. We
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subsequently applied the calculated positive and negative
agreement to adjust estimates for non-differential mis-
classification error by using a probabilistic approach [36]
(for more details see Additional file 1: eMethod 3).
To assess the sensitivity of our findings to diagnostic er-
rors or incomplete data, we ran several secondary
analyses. In the register-based study population, we re-
stricted caseness to hospital-diagnosed maternal thyroid
disorders, and also to diagnoses and redeemed prescrip-
tions recorded from 10 years before to 5 years after preg-
nancy. In both study populations, we also restricted
analyses to children with complete data on covariates. Fi-
nally, we included children who died within the first year
of life in the study population and assessed the relation-
ship of maternal thyroid disorder to infant death in case
infant death linked to maternal thyroid disorder (perhaps
with brain damage) precluded the possibility of a CP
diagnosis. All analyses were performed using StataSE
14 (64-bit).
Results
Characteristics of the study populations
In the register-based study population, 23,625 (1.9%) of
the mothers had a thyroid disorder. Hypothyroidism was
recorded in 12,929 (1.0%) and hyperthyroidism in 9943
(0.8%) of the mothers; we were unable to classify the
condition in the remaining 753 (< 0.1%) mothers with
thyroid disorders. In MOBAND, 3042 (1.6%) of the
mothers reported a thyroid disorder in pregnancy, of
whom 2229 (73.3%) reported use of thyroid medication.
More than twice as many mothers in MoBa (2.1%) than
in DNBC (1.0%) reported a thyroid disorder. Mothers
with thyroid disorders were more likely to be older, have
diabetes, and deliver preterm than mothers without the
disorder. Also, mothers with thyroid disorders were
more likely to have intermediate or higher education in
the register-based study population, were more likely to
be unemployed or receive benefits/pension, and to con-
sume less alcohol and smoke less in pregnancy in
MOBAND (Table 1).
Maternal thyroid disorder and risk of cerebral palsy
CP was diagnosed in 2798 children in the register-based
study population. Bilateral spastic CP was the most com-
mon subtype with 1490 cases, while 912 children had
unilateral spastic CP. Maternal thyroid disorder diag-
nosed or treated for the first time before pregnancy until
5 years subsequent to pregnancy was not associated with
CP overall or either of the subtypes: unilateral or bilat-
eral spastic CP (Table 2). Maternal thyroid disorder
identified during pregnancy was associated with in-
creased risk of unilateral spastic CP (adjusted OR 3.1
(95% CI: 1.2–8.4) (Table 2). Sufficient statistical power
was unavailable to address the timing of identification of
hypo- and hyperthyroidism separately. In the stratified
analyses, estimates were similar across strata of sex and
gestational ages, respectively, and no interaction was
suggested (p-values for interaction > 0.2, Additional file
1: eTable 1–2), though the estimates were imprecise.
In MOBAND, 402 children were diagnosed with CP of
whom 47.8% had bilateral, and 37.1% had unilateral spas-
tic CP. Six of the children with bilateral spastic CP were
exposed to maternal thyroid disorder, while only one child
with unilateral spastic CP was exposed, making it unfeas-
ible to confirm or deny the register findings for unilateral
spastic CP. The estimates for maternal thyroid disorder
and CP overall did not suggest an association (adjusted
OR 1.2 (95% CI: 0.6–2.4), Table 2), although an high, but
imprecise estimate of risk for bilateral spastic CP (adjusted
OR 1.9 (95% CI: 0.8–4.3)) was noted. A higher estimate of
overall CP risk (adjusted OR 2.5 (95% CI: 0.8–7.9)) was
seen in children exposed to an untreated thyroid disorder
than to a treated disorder, but these estimates were also
imprecise. Adjustment for maternal lifestyle factors did
not alter the results (Table 2).
Assessment of bias
The proportion of positive agreement between
self-reported and register-based information on maternal
thyroid disorder was 60%, while the proportion of negative
agreement was 99%. Estimates adjusted for systematic bias
were unstable but suggested that non-differential misclassi-
fication of exposure biased towards the null (Table 3).
Further, changing the categorization of maternal thyroid
disorder and restricting the analyses to complete cases did
not alter the results. Finally, we found an increased risk of
infant death in children exposed to both maternal
hypothyroidism (unadjusted OR 1.4 (95% CI: 1.1–1.9)) and
hyperthyroidism (unadjusted OR 1.9 (95% CI. 1.4–2.4)).
Discussion
Main findings
Results from the register part of this study show that
thyroid disorder in pregnancy is not related to bilateral
spastic CP, but may possibly be related to unilateral CP.
Though the statistical power of MOBAND data was lim-
ited, information on lifestyle during pregnancy enabled
us to perform more thorough control for potential con-
founders, which did not influence the results.
Potential mechanisms
We studied unilateral and bilateral spastic CP separately,
because they may have distinct etiological profiles. It has
been hypothesized that thyroid hormone deficiency can
cause CP by altering myelination, differentiation, and
migration of nerve cells [8], which would likely be
reflected in bilateral damage to the brain. An increased
risk of bilateral spastic CP was suggested in MOBAND
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data only, but the estimate was unstable, and the finding
was not replicated in the larger register-based study. The
most striking finding in this study, a three-fold increase
in risk of unilateral CP in association with thyroid dis-
order identified in pregnancy, is biological plausible. Ma-
ternal thyroid disorder may affect the coagulation
system and increase the risk of thrombosis (leading to is-
chemia) and bleeding [16, 17], and such vascular events
most likely cause unilateral spastic CP [37]. In support
of this line of reasoning, markers of coagulation abnor-
malities including Factor V Leiden mutations, which im-
plying an increased risk of thrombosis, have been linked
to spastic CP [38]; especially, the unilateral subtype,
though the evidence is sparse [39].
The male excess of CP indicates perhaps a heightened
vulnerability to brain injury in boys [40], and abnormal
thyroid hormone levels may affect boys differently than
girls [41], but we were unable to find any sex differences
in the association between maternal thyroid disorder
and the risk of CP. Further, we hypothesized that the
risk of CP in association with maternal thyroid disorder
would be elevated mainly in children born at term, as
we expect prenatal factors to play a greater role in the
etiology of CP in children born at term than in children
born preterm [40]. The estimates were unstable after
stratification by gestational age, and there was no indica-
tion of any differences in risk.
Previous findings
The syndrome of neurological cretinism provides a con-
vincing indication of a link between maternal thyroid
disturbances and CP. Children born to women with
Table 1 Characteristics of exposed versus unexposed in the register-based and MOBAND study population, respectively.
Contains data prior to multiple imputation of missing values
Danish register-based study population No = 1,270,079 MOBAND study population No = 192,918
Characteristics Exposed to maternal
thyroid disorder
No = 23,625
Unexposed
No = 1,246,454
Exposed to maternal
thyroid disorder
No = 3042
Unexposed
No = 189,876
No (%) No (%) No (%) No (%)
Maternal age
≥ 30 years 13,921 (58.9) 544,852 (43.7) 1997 (65.6) 103,084 (54.3)
Missing 0 (−) 0 (−) 0 (−) 0 (−)
Maternal occupational statusa
Unemployed/ receiving benefits or pension – – 310 (10.2) 6816 (3.6)
Missing – – 50 (1.6) 2055 (1.1)
Maternal educational levelb
Basic 4781 (20.2) 280,337 (22.5) – –
Missing 694 (2.9) 93,414 (7.5) – –
Maternal diabetes
Diabetes type 1 or 2 518 (2.2) 6362 (<1) 61 (2.0) 855 (<1)
Missing 0 (−) 0 (−) 0 (−) 0 (−)
Smoking in pregnancy
≥ 1 cigarettes/day – – 293 (9.6) 23,009 (12.1)
Missing – – 18 (<1) 900 (<1)
Alcohol consumption in pregnancy
≥ 0.5 units/week – – 529 (17.4) 50,510 (26.6)
Missing – – 206 (6.8) 10,129 (5.3)
Child’s sex
Male 11,690 (49.5) 606,514 (48.7) 1572 (51.7) 97,265 (51.2)
Missing 5 (<1) 864 (<1) 0 (−) 2 (< 1)
Gestational age
< 37 weeks (preterm) 1796 (7.6) 72,204 (5.8) 233 (7.7) 11,691 (6.2)
Missing 0 (−) 5 (< 1) 12 (< 1) 423 (<1)
Abbreviations: MOBAND MOthers and BAbies in Norway and Denmark, No number in complete case data
aSocioeconomic measure in the MOBAND study population
bSocioeconomic measure in the register-based study population
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severe iodine deficiency have a substantial risk of im-
paired cognitive and motor function, and clinical find-
ings and brain imaging compatible with CP has been
observed in children with the neurologic form of en-
demic cretinism [42]. Maternal thyroid diseases have
only been investigated in relation to risk of CP in few
studies. Nelson et al. found in a cohort study of
45,559 children, of whom 189 had CP, an increased
risk of CP in infants with a birth weight ≥ 2500 g who
were born to women with hyperthyroidism and in in-
fants exposed to maternal thyroid hormone and estro-
gen supplementation in pregnancy [7]. In another
study of 183 children with CP and 549 controls with-
out CP, more cases than controls were born to
women who were treated with thyroid hormone; how-
ever, the difference was not statistically significant
[12]. Recent register-based studies from Denmark by
Andersen et al. [28, 43] have indicated that thyroid
disorders identified subsequent to pregnancy, espe-
cially within 5 years after pregnancy, are correlated
with increased risk of attention deficit hyperactivity
disorder, autism spectrum disorder, and seizures. We
found a tendency to increased risk of unilateral spas-
tic CP in children born to women with thyroid disor-
ders identified during pregnancy. These children will
probably have been exposed to abnormal thyroid hor-
mone levels in utero, as abnormal levels may be
present for a period before the disorder is diagnosed
and treated for the first time.
Strengths and limitations
The large scale register data enabled examination of dif-
ferent subtypes of thyroid disorder and CP, but lacked
information on maternal lifestyle factors. Although the
statistical power of MOBAND was limited, among pro-
spective cohort studies, MOBAND holds by far the lar-
gest sample of CP cases with detailed information on
lifestyle collected during pregnancy, which allowed us to
address such potential confounders.
CP was verified by neuropediatricians based on clinical
presentation when the children were five-six years old,
unaware of maternal illness during pregnancy, which en-
hances the validity of the CP diagnoses. Likewise, mea-
sures of maternal thyroid disorder were not affected by
knowledge of whether the child had CP, because of the
register recording or self-reporting during pregnancy.
We restricted our analyses to children surviving to age 1
year as CP cannot reliably be diagnosed before this age.
We saw an increased risk of infant death in children pre-
natally exposed to maternal thyroid disorders. If children
with brain damage compatible with CP also are more
likely to die before CP can be diagnosed, this restriction
might have biased our results towards the null.
We did not have information on causes of thyroid dis-
orders, which may be important for understanding the
mechanism by which unregulated thyroid disorder is as-
sociated with risk of CP. Moreover, it is possible that
autoimmune conditions confound the association. Thy-
roid disorders in reproductive-age women are most
Table 3 Assessment of misclassification of exposure to maternal thyroid disorder
Agreement between sources of maternal thyroid disorder in 90,088 danish children included in both the danish register-based study population and
MOBAND study population
Register-based informationa Self-report
Unexposed Hypothyroidism Hyperthyroidism Unclassifiable Total
Unexposed 88,841 110 48 158 89,157
Hypothyroidism 164 240 17 68 489
Hyperthyroidism 213 21 147 21 402
Unclassifiable 19 14 4 3 40
Total 89,237 385 216 250 90,088
Observed proportionate agreement
Proportion of positive agreement 0.60
Proportion of negative agreement 0.99
Kappa 0.60, p < 0.001
Bias-adjusted estimates of thyroid disorder and risk of cerebral palsy
All CP Unilateral spastic CP Bilateral spastic CP
Bias-adjusted ORb (study error)c in register-based study population 0.89 (0.40–1.21) 1.20 (0.72–3.83) 0.77 (0.24–1.22)
Abbreviations: CP cerebral palsy, OR odds ratio
aThe exposure window of the register-based measure was changed to an identified thyroid disorder before pregnancy until week 18 of gestation in order to
correspond with the measure based on maternal self-report in MOBAND
bRaw estimates adjusted for misclassification using a probabilistic approach assuming non-differential misclassification of exposure. Assumptions regarding level
of sensitivity and specificity were guided by the calculated positive and negative agreement (for more details see Additional file 1: eMethod 3)
cStudy error includes both systematic error (interval encompassing 95% of the corrected estimates) and random error (95% confidence interval)
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often autoimmune in origin, and may be associated with
other autoimmune manifestations [40]. Autoimmune
disorders might lead to CP either because autoantibodies
are themselves pathogenic, or because of the presence of
inflammation in autoimmunity, which is an established
risk factor for spastic CP [44]. We adjusted for maternal
diabetes, but it is possible that confounding by other
autoimmune diseases and other abnormalities that coex-
ist with thyroid disorder, for which we did not have in-
formation, had occurred.
The comparison of measures of thyroid disorder from
different sources revealed that some non-differential
misclassification had occurred, which may have led to an
underestimation of the association of thyroid disorder
and CP. In the register data, we were unable to identify
women who had a thyroid disorder diagnosed outside
hospital settings and who did not redeem any thyroid
medication before the establishment of the Danish Na-
tional Prescription in 1995. Moreover, we may have cate-
gorized some women as exposed to maternal thyroid
disorder in pregnancy, even though the mother may
have recovered from the disease before pregnancy, e.g.
postpartum thyroiditis is often transient. In MOBAND,
some women may have been unaware of their diagnoses,
which also may have led to misclassification. However,
in the register-based study population, we used thyroid
disorder diagnosed within 5 years after pregnancy as a
proxy for subclinical and asymptomatic thyroid diseases
in pregnancy, since recent findings from DNBC based
on blood samples drawn in early pregnancy have shown
that abnormal thyroid function may be present for a
period before the disorder is identified and that asymp-
tomatic thyroid diseases are common [45]. We antici-
pate that much initially asymptomatic thyroid disorders
would have come to medical attention within 5 years,
and that the milder and most subclinical forms of thy-
roid disorders would be less likely to have an impact on
risk of CP. Moreover, as we did not have access to infor-
mation on the actual thyroid hormone level, we cannot
know whether women with an identified thyroid dis-
order actually had abnormal thyroid hormone values
during pregnancy or whether the women had a hypo- or
hyperthyroid condition due to overtreatment. The nat-
ural next step is to make use of maternal blood samples
collected during pregnancy to study the link between
maternal thyroid disorder and CP.
Conclusion
It is reassuring that maternal thyroid disorders do not
seem to be related to the predominant CP subtype, bilat-
eral spastic CP. However, our findings hint that risk of
unilateral spastic CP may be higher in children of
mothers with thyroid disorder identified in pregnancy,
which presumably is more unregulated than disorders
identified before pregnancy, since abnormal thyroid
hormone levels may be present for a period before the
disorder is diagnosed and treated for the first time. We
cannot exclude the possibility that the observed associ-
ation is due to chance or unmeasured confounding.
Replication of our findings in studies that test maternal
thyroid hormone level in early pregnancy is therefore
needed.
Additional file
Additional file 1: The file contain supplementary methods and tables.
(DOCX 32 kb)
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